Annume Vitality Lab
Your questions,
with context.
Clear answers about the research, the status of experimental compounds and Annume’s role.
Start with the distinction that matters.
Learning about a compound is different from establishing that a specific product is appropriate, available or safe for you.
What does Annume offer today?
Annume offers educational guides, research explainers and reference tools about peptide health, metabolic medicine and longevity. This website is not a medical practice or pharmacy and does not provide prescriptions or individualized treatment.
Can I order a compound from the catalog?
No. The catalog contains research references. An entry does not represent inventory, a supplier endorsement or an offer to sell. Annume has ambitions for future branded products and services, but they are not available through this catalog.
Is retatrutide FDA-approved or available from Annume?
No. As of November 7, 2026, retatrutide remains investigational. FDA states that it is not a component of an FDA-approved drug and cannot be compounded under federal law. Annume does not offer it or take reservations for future treatment.
Would FDA approval make every version of a peptide legal to sell?
No. Approval applies to a particular drug product and its labeling. It does not approve every product using the same ingredient name or every claimed use. Compounding and dispensing have separate requirements. Future approval of retatrutide would not, by itself, authorize an Annume-branded copy.
Are compounded medicines FDA-approved?
No. Compounded drugs are not FDA-approved. FDA does not review them for safety, effectiveness or quality before they are marketed. They may serve a patient-specific medical need under applicable requirements; they should not be assumed interchangeable with an approved medicine.
Does “research use only” mean a product is safe for me?
No. That label does not establish safety, purity, efficacy or lawful access for personal use. FDA has warned about products falsely labeled for research while being sold for human use. A product sold online cannot borrow the safety or results of a clinical trial merely by using the same compound name.
How should I read a new trial headline?
Check the original source, the study population, the comparator, the outcome and the follow-up time. A sponsor announcement is different from a full peer-reviewed report. Distinguish an absolute change from a relative change, and body composition from strength or physical function. Trials also need to be read for harms and treatment discontinuations.
Does weight loss or a better biomarker prove longer life?
No. Weight, biomarkers, physical function and survival are different outcomes. A study must measure the outcome in question. Benefits in a population with obesity or a particular disease do not automatically establish benefits in healthy adults seeking longevity treatment.
Is every article medically reviewed?
No. Not every article has received clinical review. AI assistance may be used in research and drafting. A named clinical reviewer is credited only when that review has actually occurred. A source-check date is not a medical-review date.
Where can I follow new research?
Visit the Annume Blog for research updates and the Research Library for broader reading. For decisions about your own health, bring your questions to a licensed clinician. This website cannot assess your medical history, eligibility or treatment needs.